Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Official Title: A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Safety, Tolerability, and Systemic Exposure of Cerdulatinib Gel, 0.37% in Adults With Vitiligo.
In Brief: Cerdulatinib 0.37% gel applied topically twice daily for 6 weeks
Ages Eligible: 18 Years to 70 Years
Start Date: September 25, 2019
Completion Date (estimated): July 2020
Status: Active, recruiting
Study ID
- ClinicalTrials.gov: NCT04103060
- Other Study ID Numbers: DMVT-502-2101
Location: Dermavant Investigational Site: Worcester, Massachusetts, United States, 01605
Contact: To learn more about this study, you or your doctor may contact Dermavant Sciences by phone +1-480-666-0844 or email dermavantclinicaltrials@dermavant.com. Please refer to this study by its ClinicalTrials.gov identifier (NCT number)
FAQOther Questions
- Vitiligo and hearing loss: any connection?
In short, NO. Recent research shows no relationship between a degree of skin depigmentation and hearing loss severity in vitiligo patients. The results of this study showed tha...
- Will it spread?
Vitiligo activity may vary considerably from person to person. In a good number of patients the disease goes on for 3-4 years and then it settles down, with one or two stubborn...
- Can a gluten-free diet help with vitiligo?
It's very unlikely. We have specifically looked into claims that gluten-free diet may ease symptoms of vitiligo, or completely reverse it, and found no firm scientific evidence ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.